Fundador de Moderna se vuelve multimillonario… por segunda ocasión: ¿Qué hizo Robert S. Langer?
CompaniesModernaMerckAssetsvacuna de ARNm contra el melanomaDiseasesmelanoma
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
Así funciona el primer dispositivo robótico de extracción de sangre del mundo: se llama Aletta y fue aprobado por la FDA (VIDEO)
CompaniesVitestroAssetsAletta
Essity compra negocio de Kenvue en Brasil
CompaniesEssityKenvueAssetsCarefreeSempre Livreo.b.
Eurofarma traz Dayvigo ao Brasil e amplia portfólio de insônia
CompaniesEurofarmaEisaiAssetsDayvigoDiseasesinsônia
Moderna y Merck crean la primera vacuna de ARNm contra el melanoma: resultados de los ensayos clínicos
CompaniesModernaMerckAssetsmRNA-4157/V940Diseasesmelanoma
Kicillof lanza espacio de Economía del conocimiento
IMSS fortalece los Centros de Radioterapia con nueva tecnología: ¿Cuántos hay en la actualidad?
Diseasescáncer
Tecnologia preditiva ajuda farmácias a evitar ruptura sazonal
CompaniesProcfit
Pilots, flight attendants at higher risk for some cancer deaths
2 sources — primary and 1 also reporting
Phoenix Children's Appoints Carolina V. Guimaraes, MD, as Vice President, Chief of Radiology
CompaniesPhoenix Children's
ZEISS CLINIC 360 receives FDA 510k clearance, amplifying patient care through simplified clinical insights
CompaniesCarl Zeiss Meditec AG
Contratación para Saphnelo, AstraZeneca
CompaniesAstraZenecaAssetsSaphneloDiseaseslupus eritematoso sistémico
Saudi Arabia allocates SR9.5 billion in August sukuk issuance
Riyadh’s King Khalid Airport launches ‘Silent Airport’ project
NTx Bio Powers Baylor College of Medicine's Manufacturing of a Personalized Cancer Vaccine in Diakonos Oncology's Phase 1 Refractory Melanoma Trial
CompaniesNTx BioBaylor College of MedicineDiakonos OncologyAssetsNTxscribeDOC1021dubodencelDiseasesrefractory melanoma
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
CompaniesRevelation BiosciencesAvance ClinicalDiseasesacute kidney injury
Complete Genomics Appoints Lauren Selig to Board of Directors
CompaniesComplete GenomicsSwiss Rockets AG
BioSkryb Genomics Names William E. Evans, Pharm.D. as Chief Executive Officer
CompaniesBioSkryb Genomics
IntraBio’s Pivotal Phase III Trial in CACNA1A-Related Disorders Is Enrolling and Is Expected to Be Over-Enrolled and Complete Recruitment in October
CompaniesIntraBio Inc.AssetslevacetylleucineDiseasesCACNA1A-related disorders
BioMarin spends up to $490m for Alesta’s bone disease candidate
CompaniesBioMarinAlesta TherapeuticsAstraZenecaAssetsALE1Diseaseshypophosphatasia